Merck's Keytruda Finds Fast Entry Into China Via Medical-Tourism Push

Merck ’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of Hainan intended to boost medical tourism.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news